0001493152-24-004348.txt : 20240130 0001493152-24-004348.hdr.sgml : 20240130 20240130170517 ACCESSION NUMBER: 0001493152-24-004348 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240129 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240130 DATE AS OF CHANGE: 20240130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTELLIGENT BIO SOLUTIONS INC. CENTRAL INDEX KEY: 0001725430 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 821512711 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39825 FILM NUMBER: 24579081 BUSINESS ADDRESS: STREET 1: 142 WEST 57TH ST FL11 CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 646-233-6971 MAIL ADDRESS: STREET 1: 142 WEST 57TH ST FL11 CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: GBS Inc. DATE OF NAME CHANGE: 20190919 FORMER COMPANY: FORMER CONFORMED NAME: Glucose Biosensor Systems (Greater China) Holdings, Inc. DATE OF NAME CHANGE: 20171214 8-K 1 form8-k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): January 29, 2024

INTELLIGENT BIO SOLUTIONS INC.

(Exact name of registrant as specified in its charter)

Delaware		001-39825		82-1512711
(State of Incorporation)		(Commission File Number)		(IRS employer identification no.)

142 West, 57th Street, 11th Floor

New York, NY 10019

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (646) 828-8258

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.01 par value		INBS		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure.

On January 29, 2024, Intelligent Bio Solutions Inc. (the “Company”) issued a press release (the “Press Release”) announcing that a leading UK timber processor and packaging manufacturer, James Jones & Sons Ltd, is now using the Company’s portable Intelligent Fingerprinting Drug Screening System that works by analyzing fingerprint sweat.

A copy of the Press Release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The foregoing disclosure is qualified in its entirety by the full text of the Press Release.

The information disclosed under Item 7.01, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be deemed incorporated by reference into any filing made under the Securities Act of 1933, except as expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

No.		Description
99.1		Press Release, dated January 29, 2024
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: January 30, 2024
	INTELLIGENT BIO SOLUTIONS INC.

	By:	/s/ Spiro Sakiris
	Name:	Spiro Sakiris
	Title:	Chief Financial Officer

EX-99.1 2 ex99-1.htm

Exhibit 99.1

Leading UK Timber Processor and Packaging Manufacturer, James Jones & Sons Ltd., Adopts Intelligent Bio Solutions’ Fingerprint Drug Screening System Across its 25 Sites and 1,300 Employees

Intelligent Fingerprinting to be used for in-house drug testing, enabling full testing control to support new James Jones drug and alcohol testing policy

Portable Intelligent Fingerprinting system easily covers testing needs across all remote locations and allows in-house ownership

NEW YORK, January 29, 2024 — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that leading UK timber processor and packaging manufacturer, James Jones & Sons Ltd is now using its revolutionary portable Intelligent Fingerprinting Drug Screening System that works by analyzing fingerprint sweat.

James Jones & Sons Ltd will use 11 readers deployed across the company’s 25 UK locations. The company will implement a random testing program for its 1,300 employees to proactively support its new substance misuse policy launched in November 2023.

Rosetta Forbes, Group Head of HR for James Jones & Sons Ltd, said, “James Jones has some 1,300 employees, many of whom operate high-risk machinery such as sawmill cutting equipment, pallet & packaging manufacturing units, and wood harvesting machinery. As an innovative company, we want to push our safety record forward, and Intelligent Fingerprinting will be central to our new substance misuse policy.”

“We are rolling out the Intelligent Fingerprinting Drug Screening System to provide in-house testing that will be available across all our sites, including our remote/rural operations, as required,” added Rosetta Forbes. “The system is a great match for our needs. It is easy for our HR and Health and Safety colleagues who are not medically trained to use. The system is non-invasive, fast, and cost-effective across our urban as well as remote locations, with easy sample collection that takes only seconds. On-site results for multiple drug groups in just ten minutes makes Intelligent Fingerprinting a very efficient and innovative solution for James Jones & Sons Ltd to adopt.”

James Jones & Sons Ltd’s in-house HR team will work collaboratively with their Health and Safety colleagues, as well as some local managers, who are all trained to use the sweat-based drug screening system to manage testing as required. The company has carefully planned the roll-out, incorporating a company-wide amnesty period that welcomes employees to approach the company for wellbeing support before the new policy came into force in December.

Harry Simeonidis, President and Chief Executive Officer of Intelligent Bio Solutions Inc., said, “For workplace testing, the Intelligent Fingerprinting Drug Screening System offers companies full control and the ability to drug test quickly, conveniently, and whenever needed. This enables organizations such as James Jones & Sons Ltd to be proactively responsible for the health and safety of its employees and customers while protecting its business reputation.”

James Jones has purchased 11 Intelligent Fingerprinting Drug Screening Systems consisting of portable DSR-Plus readers and single-use chain of custody sample collection cartridges. These will be located at the company’s testing hubs that will geographically cover their 25 locations across the UK. The company’s Australian operations are also watching the deployment with a view to potentially expand the use of the system to that region.

An introductory video demonstrating fingerprint-based drug testing in action is available here.

About Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering innovative, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. Additionally, the Company’s biosensor platform has the potential to test for up to 130 indications, ranging from glucose to immunological conditions and communicable diseases. The Company’s current customer segments include construction, manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners.

For more information, visit: http://www.ibs.inc/

About James Jones

James Jones & Sons Ltd is a 5th generation family business and one of the UK’s largest and most progressive timber processing companies with core activities in timber harvesting, sawmilling, pallets & packaging, and distribution. We operate from 25 sites across the UK, 11 Australian and 2 New Zealand sites, and employ over 2,100 people. In the UK, we operate seven sawmills throughout Scotland and the northeast of England: an engineered wood manufacturing plant in the north of Scotland and pallet and packaging operations at 14 sites across the UK. We produce high quality, British grown timber for the UK construction, landscaping, and agricultural sectors; market-leading JJI-Joists for the housebuilding and construction markets and pallets and packaging for blue chip domestic and exporting businesses. For further information on James Jones & Sons Ltd, visit: https://www.jamesjones.co.uk

Forward-Looking Statements:

Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, Intelligent Bio Solutions Inc.’s ability to develop and commercialize its diagnostic tests, realize commercial benefit from its partnerships and collaborations, and secure regulatory approvals, among others. Although Intelligent Bio Solutions Inc. believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Intelligent Bio Solutions Inc. has attempted to identify forward-looking statements by terminology, including “believes,” “estimates,” “anticipates,” “expects,” “plans,” “projects,” “intends,” “potential,” “may,” “could,” “might,” “will,” “should,” “approximately” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, included in Intelligent Bio Solutions’ public filings filed with the Securities and Exchange Commission. Any forward-looking statements contained in this release speak only as of its date. Intelligent Bio Solutions undertakes no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.

Company Contact:

Intelligent Bio Solutions Inc.

info@ibs.inc

LinkedIn | Twitter

Media Contact:

Cheryl Billson

Comma Communications

cheryl.billson@commacomms.com

+44 (0)7791 720460

EX-101.SCH 3 inbs-20240129.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 inbs-20240129_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 inbs-20240129_pre.xml XBRL PRESENTATION FILE XML 6 R1.htm IDEA: XBRL DOCUMENT

Cover	Jan. 29, 2024
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Jan. 29, 2024
Entity File Number	001-39825
Entity Registrant Name	INTELLIGENT BIO SOLUTIONS INC.
Entity Central Index Key	0001725430
Entity Tax Identification Number	82-1512711
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	142 West, 57th Street
Entity Address, Address Line Two	11th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10019
City Area Code	(646)
Local Phone Number	828-8258
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock, $0.01 par value
Trading Symbol	INBS
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false

EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 24 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://ibs.inc/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm inbs-20240129.xsd inbs-20240129_lab.xml inbs-20240129_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "INBS", "nsuri": "http://ibs.inc/20240129", "dts": { "inline": { "local": [ "form8-k.htm" ] }, "schema": { "local": [ "inbs-20240129.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "inbs-20240129_lab.xml" ] }, "presentationLink": { "local": [ "inbs-20240129_pre.xml" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "report": { "R1": { "role": "http://ibs.inc/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-01-29", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-01-29", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://ibs.inc/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001493152-24-004348-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-004348-xbrl.zip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end XML 16 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001725430 2024-01-29 2024-01-29 iso4217:USD shares iso4217:USD shares false 0001725430 8-K 2024-01-29 INTELLIGENT BIO SOLUTIONS INC. DE 001-39825 82-1512711 142 West, 57th Street 11th Floor New York NY 10019 (646) 828-8258 false false false false Common Stock, $0.01 par value INBS NASDAQ true false